Search

Search results

18 results found

Project Ex Vivo

Project Ex Vivo is a groundbreaking collaboration between Microsoft Research and the Broad Institute. We harness the power of AI and machine learning to guide our cancer research. This initiative aims to define, engineer, and target cell states in cancer, driving innovative advancements in precision oncology.

News Headline 6

News: July 21, 2022

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus...

Srivatsan Raghavan

Person: Assistant Professor, Co-Director Ex Vivo, Harvard Medical School

Srivatsan Raghavan, MD/PhD Dr. Srivatsan Raghavan, MD, PhD, is a medical oncologist and physician-scientist at the Dana-Farber Cancer Institute and Brigham and Women’s Hospital and an Instructor in Medicine at Harvard Medical School. He specializes in the clinical care of patients with...

News Headline 2

News: July 21, 2022

News Headline 4

News: July 21, 2022

Team

Page

Andrew Navia

Person: Research Scientist, Broad Institute

Andrew Navia, PhD Andrew is interested in using single-cell techniques to study new RNA states in solid tumors. This builds on work completed during his PhD in the Shalek Lab at MIT. In his free time he enjoys hiking and running.

Tsukasa Shibue

Person: Senior Research Scientist, Broad Institute

Tsukasa Shibue, PhD Tsukasa is an expert of target(s). On weekdays, he works on validation projects of potential cancer therapeutic targets with a goal of saving patients' lives. On weekends, he goes to Target to buy goods that might save his own life.

News Headline 3

News: July 21, 2022

About

Page